Home  |  Doctors  | Students  |  Organizations |  Health & Fitness  |  News  | Message Boards  |  About Us  |


 


















































 








 













Patrons Doctor
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Back to List

Diabetic Nephropathy
Overview

Diabetic nephropathy is kidney disease that develops as a result of diabetes mellitus (DM). DM, also called simply diabetes, affects approximately 5% of the U.S. population. This disease damages many organs, including the eyes, nerves, blood vessels, heart, and kidneys. DM is the most common cause of kidney failure in the United States and accounts for over one-third of all patients who are on dialysis.

Diabetes mellitus (DM)
Diabetes mellitus is a disorder in which the body is unable to metabolize carbohydrates (e.g., food starches, sugars, cellulose) properly. The disease is characterized by excessive amounts of sugar in the blood (hyperglycemia) and urine; inadequate production and/or utilization of insulin; and by thirst, hunger, and loss of weight.

Diabetics who require daily insulin shots to maintain life have insulin-dependent diabetes mellitus, or DM 1. In this type of diabetes, the pancreas secretes little or no insulin and the blood sugar level remains high, unless treated. DM 1 usually occurs in children and young adults and is often called juvenile onset diabetes. Onset of the disease is abrupt. The patient becomes very sick and requires immediate insulin therapy. Approximately 1 million people in the United States have DM 1.

Non-insulin-dependent diabetes, or DM 2, differs from DM 1 in that the main problem is a peripheral resistance to the action of the insulin. DM 2 usually occurs in adults over the age of 40 who are overweight and have a family history of the disease. Some patients can manage their diabetes with weight loss and changes in their diet. Others require medication, and many with DM 2 eventually require insulin. Onset is gradual, and patients may be sick for quite some time without knowing it. Nearly 95% of diabetics are diagnosed with DM 2.

Signs and Symptoms

Approximately 25% to 40% of patients with DM 1 ultimately develop diabetic nephropathy (DN), which progresses through about five predictable stages.

Stage 1 (very early diabetes) Increased demand upon the kidneys is indicated by an above-normal glomerular filtration rate (GFR).

Stage 2 (developing diabetes) The GFR remains elevated or has returned to normal, but glomerular damage has progressed to significant microalbuminuria (small but above-normal level of the protein albumin in the urine). Patients in stage 2 excrete more than 30 mg of albumin in the urine over a 24-hour period. Significant microalbuminuria will progress to end-stage renal disease (ESRD). Therefore, all diabetes patients should be screened for microalbuminuria on a routine (yearly) basis.

Stage 3 (overt, or dipstick-positive diabetes) Glomerular damage has progressed to clinical albuminuria. The urine is "dipstick positive," containing more than 300 mg of albumin in a 24-hour period. Hypertension (high blood pressure) typically develops during stage 3.

Stage 4 (late-stage diabetes) Glomerular damage continues, with increasing amounts of protein albumin in the urine. The kidneys’ filtering ability has begun to decline steadily, and blood urea nitrogen (BUN) and creatinine (Cr) has begun to increase. The glomerular filtration rate (GFR) decreases about 10% annually. Almost all patients have hypertension at stage 4.

Stage 5 (end-stage renal disease, ESRD) GFR has fallen to approximately 10 milliliters per minute (<10 mL/min) and renal replacement therapy (i.e., hemodialysis, peritoneal dialysis, kidney transplantation) is needed.

Progression through these five stages is rather predictable because the onset of DM 1 can be identified, and most patients are free from age-related medical problems.

An estimated 5% to 15% of DM 2 cases also progress through the five stages of diabetic nephropathy (DN), but the timeline is not as clear. Some patients advance through the stages very quickly.

Diagnosis

Early screening for microalbuminuria is essential for all patients with diabetes. Aggressive intervention can delay and possibly stop progression through the stages of diabetic nephropathy (DN). Patients often seek medical attention only after having progressed to stage 3 or 4. Those who have reached stage 3 should be referred to a nephrologist (kidney specialist). The nephrologist monitors ongoing management and conducts further diagnostic studies to exclude nondiabetic causes for protein in the urine (proteinuria).

Treatment

Treatment for diabetic nephropathy attempts to manage and slow the progression of the disease.

Aggressive blood pressure control is by far the most important factor in protecting kidney function, regardless of the stage of DN. The goal of treatment is:

  • 120 – 130 mm Hg systolic blood pressure and
  • 70 – 80 mm Hg diastolic blood pressure.

Angiotensin-converting enzyme (ACE) inhibitors protect the kidneys more effectively than other antihypertensive medications. A new class of blood pressure medications known as angiotensin-receptor blockers (ARBs) may offer comparable protection. Patients who cannot tolerate ACE inhibitors may use an ARB (e.g., losartan, valsartan). Maximum doses of an ACE along with an ARB may provide additional renal protection in people who can tolerate the medications. Both ACE inhibitors and ARBs can cause hyperkalemia (abnormally high level of potassium in the blood) in patients with chronic renal failure.

Strict blood sugar control is important in the protection of kidney function. Intensive blood sugar regulation requires frequent monitoring and commitment.

Dietary protein restriction is minimally protective. A high-protein diet (e.g., the Atkins diet) can further damage the kidneys in people with diabetic nephropathy and/or chronic renal failure (CRF). Protein restriction must be cautiously implemented because of the risk for malnutrition. In general, dietary protein intake should be limited to 0.6 to 0.8 grams per kilogram (0.02 – 0.028 oz/lb) of body weight each day.

Renal Replacement Therapy
Once patients with DN progress to stage 5 (end-stage renal disease, ESRD), renal replacement therapy (RRT) is implemented. The RRT options for DN patients include the following:

  • Hemodialysis, removal of the blood’s waste products through filtration outside of the body
  • Peritoneal dialysis, filtration through the membrane lining the abdominal cavity; fluid is instilled into the peritoneal space, and then drained
  • Kidney transplantation

Patients with DM 1 are possible candidates for combined kidney and pancreas transplantation. A healthy insulin-producing pancreas eliminates the diabetes and the potential for developing diabetic nephropathy.

Back to List